2017年《自然。方法》上的一篇文章说基因编辑技术CRISPR有重大缺陷（An article in Nature Methods published in May 2017 suggested that CRISPR-Cas9 could have serious drawbacks.）这引起相关公司股票大跌。

现在证明，他们的质疑文章错了，说CRISPR-Cas9有缺陷完全是无事生非。他们进行了更正，原来的文章也撤下了。

（As it turned out, the scientists who wrote the article were wrong, and the scientists at the biotechs focusing on CRISPR were right. The original team that wrote the Nature Methods article posted a corrigendum (an error correction) last week on bioRxiv (pronounced "bioarchive"), a website that provides access to preprint versions of biology papers. The original online version of the initial article on Nature Methods was also subsequently retracted.）

Oops! CRISPR Concerns Turn Out to be a Big Nothingburger

https://www.yahoo.com/news/oops-crispr-concerns-turn-big-133200642.html